Change - Announcement of Cessation::Cessation of Chief Financial Officer

Issuer & Securities

Issuer/ Manager
AUTAGCO LTD.
Securities
AUTAGCO LTD - SGXE12305384 - WNH
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
05-Nov-2026 22:07:19
Status
New
Announcement Sub Title
Cessation of Chief Financial Officer
Announcement Reference
SG261105OTHR0UFE
Submitted By (Co./ Ind. Name)
Stanley Li
Designation
Executive Chairman and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
This announcement has been reviewed by the Company's sponsor, SAC Capital Private Limited (the "Sponsor").

This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Lee Khai Yinn (Tel: (65) 6232 3210), at 1 Robinson Road, #21-01 AIA Tower, Singapore 048542.

Additional Details

Name of person
Yeo Choon Tat
Age
73
Is effective date of cessation known?
Yes
If yes, please provide the date.
16/11/2026
Detailed reason(s) for cessation
Mr. Yeo Choon Tat ("Mr. Yeo") was appointed to support and provide guidance to the Group during the transitional period when there were changes to the Board and the Management of the Group. Having fulfilled his role and achieved the intended objectives, Mr. Yeo has decided to resign from his position and retire from full-time employment.

The Company would like to express its gratitude and appreciation towards Mr. Yeo for his valuable contributions to the Company during his tenure.

The Sponsor, after having interviewed Mr. Yeo, is satisfied that, save as disclosed in this announcement, there are no material reasons for the resignation of Mr. Yeo as the Chief Financial Officer of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of appointment to current position
24/04/2026
Job title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Financial Officer
Role and responsibilities
Executive. Responsible for the supervision of the Group's financial reporting, the management of the finance team, the compliance with listing and regulatory requirements and the review of internal control systems and procedures.
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of independent directors currently resident in Singapore (taking into account this cessation)
2
Do independent directors make up at least one-third of the board (taking into account this cessation)?
Yes
Number of cessations of appointments specified in Mainboard Rule 704(7) or Catalist Rule 704(6) over the past 12 months
6
Shareholding interest in the listed issuer and its subsidiaries
No
Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Nil
Other Directorships
Past (for the last 5 years)
Directorship:
Camsing Healthcare Limited
Nature's Farm Pte Ltd
Nature's Farm Retail Pte Ltd
Present
Directorship:
Nil